Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2385-2393

  Thanamayooran, Siva ^a   Rose, Caren ^a   Hirsch, David J ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Chronic kidney disease; Hyperphosphataemia; Hypertension; Multidisciplinary care; Pre dialysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BICARBONATE; CALCIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; IRON; PHOSPHATE; PHOSPHATE BINDING AGENT; VITAMIN D DERIVATIVE;

ADULT; AGED; ANEMIA; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD PRESSURE REGULATION; CENTRAL VENOUS CATHETER; CREATININE CLEARANCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIETITIAN; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERPHOSPHATEMIA; INFORMATION PROCESSING; KIDNEY DISEASE; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; NEPHROLOGY; NURSING; OUTPATIENT CARE; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

AGED; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HOSPITALS, CHRONIC DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NOVA SCOTIA; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY;

EID: 27644514195     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi024     Document Type: Article

References (20)

1. Levin A, Lewis M, Mortiboy P et al. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 1997; 29: 533-540
2. Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004; 44: 706-714
3. Kinchen KS, Sadler J, Fink N et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137: 479-486
4. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 [Suppl 1]: S1-S290
5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 [Suppl 3]: S1-S201
6. Curtis BM, Ravani P, Malberti F et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147-154
7. Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis 2002; 40: 30-36
8. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C. Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999; 55: 1878-1884
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
10. National Kidney Foundation. K/DOQI clinical practice guideline to define chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
11. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825-835
12. Kausz AT, Khan SS, Abichandani R et al. Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol 2001; 12: 1501-1507
13. Froissart M, Rossert J, Jacquot C et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773
14. Coresh J, Wei GL, McQuillan G et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States. Arch Intern Med 2001; 161: 1207-1216
15. Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant 2002; 17: 1426-1433
16. Schwenger V, Ritz E. Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant 1998; 13: 3091-3095
17. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
18. Clase CM, Kiberd BA, Garg AX. Relationship between metabolic complications and clearance levels in participants in NHANES III. J Am Soc Nephrol 2002; 13: 424A
19. Hsu C, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 2002; 17: 1419-1425
20. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004; 44 [Suppl 2]: S34-S38